Exercise as Treatment for Patients With Inclusion Body Myositis

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

May 28, 2025

Study Completion Date

May 28, 2025

Conditions
Inclusion Body Myositis (IBM)Feasibility Study
Interventions
OTHER

Exercise group in a hospital setting

Participants will exercise in a group once a week for 16 weeks in a hospital setting.

Trial Locations (1)

0424

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

The Dam Foundation

OTHER

collaborator

The Norwegian Rheumatism Association

OTHER

lead

Oslo University Hospital

OTHER

NCT06644482 - Exercise as Treatment for Patients With Inclusion Body Myositis | Biotech Hunter | Biotech Hunter